Dr Helen O’Neill is a molecular geneticist at University College London (UCL) currently doing research in the Embryology, IVF and Reproductive Genetics Group at the Institute for Women’s Health in UCL. Here, she works on the morphokinetics of preimplantation embryos and is using CRISPR genome editing to assess the treatment and understanding of sex chromosome disorders and neuromuscular disorders. Helen is also the Programme Director for Reproductive Science and Women’s Health at UCL and lectures both masters and medical students.

Últimos Artículos

Salud y sistemas de salud

Scientists have edited human embryos to safely remove disease for the first time

Scientists in the US have released a paper showing that they have successfully edited human embryos to correct a mutation that causes an inheritable heart condition. The findings are huge...

03 ago 2017

Helen O'Neill

Últimos Artículos

Scientists have edited human embryos to safely remove disease for the first time